Bright Minds Biosciences Ownership | Who Owns Bright Minds Biosciences?
Bright Minds Biosciences Ownership Summary
Bright Minds Biosciences is owned by 109.72% institutional investors, 27.28% insiders. Cormorant asset management, lp is the largest institutional shareholder, holding 23.74% of DRUG shares. AdvisorShares Psychedelics ETF is the top mutual fund, with 0.16% of its assets in Bright Minds Biosciences shares.
DRUG Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Bright Minds Biosciences | 109.72% | 27.28% | -37.00% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Idea | Psychedelic Stocks List | 21.13% | 12.05% | 66.82% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Cormorant asset management, lp | 1.06M | 23.74% | $38.16M |
Janus henderson group | 508.78K | 11.40% | $18.39M |
Commodore capital lp | 500.00K | 11.20% | $18.01M |
Ra capital management | 460.83K | 10.33% | $16.60M |
Sio capital management | 451.79K | 10.12% | $16.27M |
Perceptive advisors | 403.65K | 9.04% | $14.54M |
Vivo capital | 251.57K | 5.64% | $9.06M |
Logos global management lp | 245.00K | 5.49% | $8.82M |
Ikarian capital | 152.21K | 3.41% | $5.48M |
Point72 asset management | 135.19K | 3.03% | $4.87M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Sio capital management | 451.79K | 4.58% | $16.27M |
Acuta capital partners | 69.12K | 2.50% | $2.49M |
Cormorant asset management, lp | 1.06M | 2.10% | $38.16M |
Commodore capital lp | 500.00K | 1.32% | $18.01M |
Logos global management lp | 245.00K | 1.03% | $8.82M |
Vivo capital | 251.57K | 1.02% | $9.06M |
Ikarian capital | 152.21K | 0.75% | $5.48M |
Perceptive advisors | 403.65K | 0.40% | $14.54M |
Ra capital management | 460.83K | 0.22% | $16.60M |
Atika capital management | 15.00K | 0.06% | $540.30K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Cormorant asset management, lp | 1.06M | 2.10% | 1.06M |
Janus henderson group | 508.78K | 0.01% | 508.78K |
Commodore capital lp | 500.00K | 1.32% | 500.00K |
Ra capital management | 460.83K | 0.22% | 460.83K |
Sio capital management | 451.79K | 4.58% | 451.79K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Advisorshares investments | 3.08K | 0.02% | -179.34K |
National bank of canada /fi/ | 92.00 | - | -4.87K |
Aspire private capital | - | - | -100.00 |
Blackrock funding, inc. /de | 1.00 | - | - |
Citigroup | 1.00 | - | 1.00 |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Cormorant asset management, lp | 1.06M | 2.10% | 1.06M | $38.16M |
Janus henderson group | 508.78K | 0.01% | 508.78K | $18.39M |
Commodore capital lp | 500.00K | 1.32% | 500.00K | $18.01M |
Ra capital management | 460.83K | 0.22% | 460.83K | $16.60M |
Sio capital management | 451.79K | 4.58% | 451.79K | $16.27M |
Sold Out
Holder | Change |
---|---|
Aspire private capital | -100.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 30 | 400.00% | 4,896,857 | 2456.48% | 109 | 595.65% | 27 | 575.00% | 2 | 100.00% |
Sep 30, 2024 | 6 | - | 191,547 | -3.03% | 4 | 21.91% | 4 | 300.00% | 1 | -50.00% |
Jun 30, 2024 | 6 | -14.29% | 197,540 | -7.42% | 4 | 19.37% | 1 | -75.00% | 2 | 100.00% |
Mar 31, 2024 | 7 | - | 213,375 | -6.45% | 4 | 13.57% | 4 | - | 1 | - |
Dec 31, 2023 | 7 | 40.00% | 228,082 | 17.26% | 5 | 22.32% | 4 | 33.33% | 1 | -50.00% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
AdvisorShares Psychedelics ETF | 11.28K | 0.16% | - |
Eastern Shore Small Cap Equity | 8.70K | 0.12% | 8.70K |
Fidelity Nasdaq Composite Index | 3.34K | 0.05% | - |
Eastern Shore US Small Cap CIT | 1.40K | 0.02% | 1.40K |
iShares Neuroscience and Healthcare ETF | 521.00 | 0.01% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Nov 04, 2024 | Cormorant Asset Management, LP | - | Buy | $4.00M |
Oct 16, 2024 | Cormorant Asset Management, LP | - | Buy | $922.63K |
Oct 15, 2024 | Cormorant Asset Management, LP | - | Buy | $56.93K |
Oct 15, 2024 | Cormorant Asset Management, LP | - | Buy | $224.60K |
Oct 16, 2024 | Cormorant Asset Management, LP | - | Buy | $171.81K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | 12 | - |
DRUG Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools